TRPM2 inhibition also leads to increased DNA damage and cytotoxicity in triple-negative or estrogen-receptor-positive breast cancer, reducing survival and restrain migration of tongue carcinoma, and enhancing the radiation sensitivity in T-cell leukemia [14]. This evidence concerns the gene TRPM2 and T-cell leukemia.